Latest Breaking News On - Jianzhong zhang - Page 1 : vimarsana.com

Chinese GPU Maker Moore Threads Lays Off Workers, Restructures After US Sanctions

Moore Threads was sanctioned by the U.S. government last month, and the layoffs are a direct response.

LNK01001 Achieves Primary End Point in Phase II Trial for Atopic Dermatitis

Patients given LNK01001 showed significant improvement in Eczema Area and Severity Index scores over placebo.

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

Crisaborole Ointment Found to be Effective for Atopic Dermatitis in Younger Patients from China, Japan

New phase 3 data on patients with eczema in China and Japan showed that crisaborole, 2%, was efficacious and safe in patients aged 2 and older, lining up with data from studies done in Western countries.

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

Kintor Pharma Announces 2022 Annual Results and -2-

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

Kintor Pharmaceutical : Pharma Announces 2022 Annual Results and Recent Business Progress

Suzhou, March 30, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business... | March 30, 2023

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today... | March 30, 2023

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 31, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended 31 December 2022. Business Highlights Dr. Youzhi Tong, founder, Chairman, and CEO of Kintor Pharma, commented, 2022 has been a challenging year for...